Completed PHASE1 INTERVENTIONAL 1-arm NCT00503191

NeuroModulation Technique Treatment of Autism (NMT)

Intention-based Therapy for Autism Spectrum Disorder: Promising Results of a Wait-List Control Study in Children

Sponsor: NeuroModulation Technique Research Institute

Conditions Autism Neurodevelopmental Disorder

Updated 5 times since 2017 Last updated: Jan 19, 2014 Started: Jul 31, 2007 Primary completion: Feb 28, 2009 Completion: Feb 28, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Autism and Neurodevelopmental Disorder, this trial is completed. The trial is conducted by NeuroModulation Technique Research Institute and has accumulated 5 data snapshots since 2007. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NeuroModulation Technique Research Institute

Data source: NeuroModulation Technique Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Dallas, United States